Extract

This is a Phase 4 open label, non-interventional, multi-center study to evaluate the safety of Enbrel (etanercept) treatment in patients receiving etanercept 25mg sc twice weekly or 50mg of etanercept once weekly. The improvement of health-related quality of life will also be evaluated.

Inclusion criteria

• Ankylosing spondylitis ,Arthritis, Psoriatic ,Arthritis (rheumatoid) ,Spondylitis, Ankylosing

Links

• nct
• ictrp